Mobia Medical, Inc. Common Stock (MOBI) Stock Score, Valuation & Financial Research

Mobia Medical, Inc. Common Stock is in the Healthcare sector and Medical - Specialties industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. A complete Wall Street Score is not currently available.

Quick answer for MOBI

Mobia Medical, Inc. Common Stock does not currently have a complete Wall Street Score. The stored market price is USD 9.37. These figures are a research snapshot, not a buy or sell recommendation.

What Mobia Medical, Inc. Common Stock does

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.

Company business and revenue

Research reporting period: 2025-12-31. A research update is not a new financial filing.

How the company makes money

Mobia Medical generates revenue through the commercialization and sale of its proprietary neurostimulation medical devices. The company operates a direct sales model, providing implantable systems that combine vagus nerve stimulation with rehabilitation therapy to healthcare providers for the treatment of chronic motor impairments in post-stroke patients.

Products and services

The Vivistim System, an FDA-approved implantable neurostimulation device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients.

Brands and product families

Vivistim System — The company's primary FDA-approved implantable device for stroke rehabilitation. Source

Customer types

Hospitals; Physicians.

Suppliers, materials and equipment

Contract Manufacturing — The company utilizes third-party contract manufacturers for the production of its medical device components. Source

Business strengths to evaluate

FDA-approved proprietary neurostimulation technology Source
Rapid commercial growth since 2023 launch Source

Business risks and research considerations

Dependence on third-party manufacturers Source
Operating losses and need for continued capital Source

Sources: Company research source · Vivistim System · Operating losses and need for continued capital

Company research refreshed 2026-10-12. This is saved research, not a live check of company relationships. Check the reporting period and source disclosures. Financial figures and scores follow their separate update schedules.

MOBI financial snapshot

Statement amounts: USD. Quote amounts: USD. No exchange-rate conversion is performed in this snapshot. Market-capitalization currency is not supplied by this projection.

Wall Street Score:: Not currently available
Stored price:: USD 9.37
Market capitalization:: 311.54M (currency not supplied)
Revenue:: USD 32.04M
Net income:: USD -46.5M
Free cash flow:: USD -46.06M
Cash:: USD 177.09M
Total debt:: USD 8.43M
EPS:: USD -0.02

What stands out

Free cash flow is USD -46.06M, negative for the stored period.
The balance sheet shows USD 177.09M of cash versus USD 8.43M of total debt, an excess of cash over debt on these two reported measures.
The current research record carries a limited financial history warning, which should be reviewed alongside the score.

Company-specific financial comparisons

The following are calculated from saved company data, not forecasts or statements about future performance. Differences in reporting dates or units can make a ratio misleading; verify the original filings.

Free cash flow is -143.8% of stored revenue. This is a simple cross-field ratio, not a verified same-period cash conversion margin; confirm reporting periods before comparison.
Net income equals -145.1% of stored revenue. This is an indicative ratio only; accounting periods and units should be verified in filings.
Cash exceeds debt by USD 168.66M using the stored balance-sheet values. This does not include other obligations or restricted cash.

Questions worth answering for MOBI

Use these questions to check the stored figures against the latest company filings. They identify issues to investigate; they are not findings about management's plans or future results.

How long can MOBI fund negative free cash flow using its current cash position before it may need more debt or new shares?
How is MOBI likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
What specifically needs to improve for MOBI to reach sustainable profitability?
What does the current limited financial history warning mean for the reliability or interpretation of MOBI's score?

What the numbers mean

A complete valuation score is not currently available, so valuation should be checked using the available earnings, cash-flow and price data.

A complete financial score is not currently available, so investors should review cash, debt, earnings and cash flow directly.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-10-05.

Research-input completeness: 55% of the scoring inputs required for this public page are currently available.

How to research MOBI

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.